1.29
7.86%
-0.11
Dopo l'orario di chiusura:
1.28
-0.01
-0.78%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TXMD stock touches 52-week low at $1.43 amid market challenges - Investing.com
TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023) - Yahoo Finance
TherapeuticsMD, Inc. (NASDAQ:TXMD) Sees Large Increase in Short Interest - Defense World
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift - TipRanks
TherapeuticsMD: Q3 Earnings Snapshot - Houston Chronicle
TherapeuticsMD Inc (TXMD) Reports Third Quarter 2024 Earnings: S - GuruFocus.com
TherapeuticsMD Shifts Focus with Lower Q3 Losses - TipRanks
TherapeuticsMD Narrows Q3 Loss by 60%, Weighs Strategic Options Amid Revenue Growth | TXMD Stock News - StockTitan
TherapeuticsMD Inc. stock remains steady Monday, underperforms market - MarketWatch
TherapeuticsMD Inc. stock remains steady Friday, underperforms market - MarketWatch
TherapeuticsMD Inc. stock remains steady Wednesday, underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch
TherapeuticsMD Inc. stock rises Thursday, still underperforms market - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
TherapeuticsMD Inc. stock remains steady Thursday, underperforms market - MarketWatch
Sexual Wellness Market to Witness 4.7% CAGR by 2031 | SkyQuest Technology - Benzinga
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):